Monday, August 19, 2019

Interregional differences in somatic genetic landscape diversify prognosis in glioblastoma

Researchers have conducted the largest-ever retrospective cohort study for Japanese patients with glioblastoma (GBM), proposing an underlying prognosis biomarker responsible for the survival difference between two cohorts: an original Japanese cohort and a dataset from The Cancer Genome Atlas (TCGA).

from Top Health News -- ScienceDaily https://ift.tt/2MmUYyp
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

New drugs could wipe out the “zombie cells” linked to cancer and aging

Researchers found a new way to kill harmful “zombie” cells that linger after chemotherapy and help cancers become more aggressive. These sen...